Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib plus FP chemotherapy as adjuvant treatment for operable gastric carcinoma
ChiCTR-TRC-11001309Phase 4Completed
- Sponsor
- The First Hospital of Lanzhou University
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of celecoxib in gastric adenocarcinoma and esophagogastric junction cancer (2 arms), sponsored by The First Hospital of Lanzhou University. Primary endpoint: Disease-free survival. Started Jun 2011; status: completed.
02
Drugs
celecoxib
03
Conditions
gastric adenocarcinomaesophagogastric junction cancer
Beyond the preview
Go deeper on ChiCTR-TRC-11001309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001309.